Osteomyelitis

被引:1473
作者
Lew, DP
Waldvogel, FA
机构
[1] Univ Hosp Geneva, Infect Dis Serv, Dept Internal Med, CH-1211 Geneva 14, Switzerland
[2] Univ Hosp Geneva, Serv Med 2, Dept Internal Med, CH-1211 Geneva 14, Switzerland
关键词
D O I
10.1016/S0140-6736(04)16727-5
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Bone and joint infections are painful for patients and frustrating for both them and their doctors. The high success rates of antimicrobial therapy in most infectious diseases have not yet been achieved in bone and joint infections owing to the physiological and anatomical characteristics of bone. The key to successful management is early diagnosis, including bone sampling for microbiological and pathological examination to allow targeted and long-lasting antimicrobial therapy. The various types of osteomyelitis require differing medical and surgical therapeutic strategies. These types include, in order of decreasing frequency: osteomyelitis secondary to a contiguous focus of infection (after trauma, surgery, or insertion of a joint prosthesis); that secondary to vascular insufficiency (in diabetic foot infections); or that of haematogenous origin. Chronic osteomyelitis is associated with avascular necrosis of bone and formation of sequestrum (dead bone), and surgical debridement is necessary for cure in addition to antibiotic therapy. By contrast, acute osteomyelitis can respond to antibiotics alone. Generally, a multidisciplinary approach is required for success, involving expertise in orthopaedic surgery, infectious diseases, and plastic surgery, as well as vascular surgery, particularly for complex cases with soft-tissue loss.
引用
收藏
页码:369 / 379
页数:11
相关论文
共 103 条
  • [1] Abdul-Karim FW, 1998, MODERN PATHOL, V11, P427
  • [2] Alonge T O, 2002, West Afr J Med, V21, P302
  • [3] Alonge TO, 2002, INT J CLIN PRACT, V56, P353
  • [4] Vancomycin in surgical infections due to meticillin-resistant Staphylococcus aureus with heterogeneous resistance to vancomycin
    Ariza, J
    Pujol, M
    Cabo, J
    Peña, C
    Fernández, N
    Liñares, J
    Ayats, J
    Gudiol, F
    [J]. LANCET, 1999, 353 (9164) : 1587 - 1588
  • [5] Genome and virulence determinants of high virulence community-acquired MRSA
    Baba, T
    Takeuchi, F
    Kuroda, M
    Yuzawa, H
    Aoki, K
    Oguchi, A
    Nagai, Y
    Iwama, N
    Asano, K
    Naimi, T
    Kuroda, H
    Cui, L
    Yamamoto, K
    Hiramatsu, K
    [J]. LANCET, 2002, 359 (9320) : 1819 - 1827
  • [6] Physiology and antibiotic susceptibility of Staphylocoecus aureus small colony variants
    Baumert, N
    Von Eiff, C
    Schaaff, F
    Peters, G
    Proctor, RA
    Sahl, HG
    [J]. MICROBIAL DRUG RESISTANCE, 2002, 8 (04) : 253 - 260
  • [7] Detection of differential gene expression in biofilm-forming versus planktonic populations of Staphylococcus aureus using micro-representational-difference analysis
    Becker, P
    Hufnagle, W
    Peters, G
    Herrmann, M
    [J]. APPLIED AND ENVIRONMENTAL MICROBIOLOGY, 2001, 67 (07) : 2958 - 2965
  • [8] Mutation of sarA in Staphylococcus aureus limits biofilm formation
    Beenken, KE
    Blevins, JS
    Smeltzer, MS
    [J]. INFECTION AND IMMUNITY, 2003, 71 (07) : 4206 - 4211
  • [9] Outpatient parenteral antimicrobial therapy (OPAT) for the treatment of osteomyelitis:: evaluation of efficacy, tolerance and cost
    Bernard, L
    El-hajj
    Pron, B
    Lotthé, A
    Gleizes, V
    Signoret, F
    Denormandie, P
    Gaillard, JL
    Perronne, C
    [J]. JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2001, 26 (06) : 445 - 451
  • [10] Trends in the treatment of orthopaedic prosthetic infections
    Bernard, L
    Hoffmeyer, P
    Assal, M
    Vaudaux, P
    Schrenzel, J
    Lew, D
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2004, 53 (02) : 127 - 129